Literature DB >> 28462223

Solving the puzzle of pluripotent stem cell-derived cardiomyocyte maturation: piece by piece.

David J Lundy1, Desy S Lee1, Patrick C H Hsieh1.   

Abstract

There is a growing need for in vitro models which can serve as platforms for drug screening and basic research. Human adult cardiomyocytes cannot be readily obtained or cultured, and so pluripotent stem cell-derived cardiomyocytes appear to be an attractive option. Unfortunately, these cells are structurally and functionally immature-more comparable to foetal cardiomyocytes than adult. A recent study by Ruan et al., provides new insights into accelerating the maturation process and takes us a step closer to solving the puzzle of pluripotent stem cell-derived cardiomyocyte maturation.

Entities:  

Keywords:  Stem cells; cardiomyocyte; differentiation; maturation

Year:  2017        PMID: 28462223      PMCID: PMC5395477          DOI: 10.21037/atm.2017.01.44

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  20 in total

Review 1.  ES and iPS cell research for cardiovascular regeneration.

Authors:  Jun K Yamashita
Journal:  Exp Cell Res       Date:  2010-04-10       Impact factor: 3.905

Review 2.  Small animal models of heart failure: development of novel therapies, past and present.

Authors:  Richard D Patten; Monica R Hall-Porter
Journal:  Circ Heart Fail       Date:  2009-03       Impact factor: 8.790

3.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

4.  Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes.

Authors:  Kavitha T Kuppusamy; Daniel C Jones; Henrik Sperber; Anup Madan; Karin A Fischer; Marita L Rodriguez; Lil Pabon; Wei-Zhong Zhu; Nathaniel L Tulloch; Xiulan Yang; Nathan J Sniadecki; Michael A Laflamme; Walter L Ruzzo; Charles E Murry; Hannele Ruohola-Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

Review 5.  Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Xiulan Yang; Lil Pabon; Charles E Murry
Journal:  Circ Res       Date:  2014-01-31       Impact factor: 17.367

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability.

Authors:  Paul W Burridge; David Anderson; Helen Priddle; Maria D Barbadillo Muñoz; Sarah Chamberlain; Cinzia Allegrucci; Lorraine E Young; Chris Denning
Journal:  Stem Cells       Date:  2006-12-21       Impact factor: 6.277

8.  Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.

Authors:  Scott D Lundy; Wei-Zhong Zhu; Michael Regnier; Michael A Laflamme
Journal:  Stem Cells Dev       Date:  2013-04-05       Impact factor: 3.272

9.  Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.

Authors:  James J H Chong; Xiulan Yang; Creighton W Don; Elina Minami; Yen-Wen Liu; Jill J Weyers; William M Mahoney; Benjamin Van Biber; Savannah M Cook; Nathan J Palpant; Jay A Gantz; James A Fugate; Veronica Muskheli; G Michael Gough; Keith W Vogel; Cliff A Astley; Charlotte E Hotchkiss; Audrey Baldessari; Lil Pabon; Hans Reinecke; Edward A Gill; Veronica Nelson; Hans-Peter Kiem; Michael A Laflamme; Charles E Murry
Journal:  Nature       Date:  2014-04-30       Impact factor: 49.962

10.  Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.

Authors:  Chris Denning; Viola Borgdorff; James Crutchley; Karl S A Firth; Vinoj George; Spandan Kalra; Alexander Kondrashov; Minh Duc Hoang; Diogo Mosqueira; Asha Patel; Ljupcho Prodanov; Divya Rajamohan; William C Skarnes; James G W Smith; Lorraine E Young
Journal:  Biochim Biophys Acta       Date:  2015-10-31
View more
  4 in total

1.  N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.

Authors:  Xi Lou; Meng Zhao; Chengming Fan; Vladimir G Fast; Mani T Valarmathi; Wuqiang Zhu; Jianyi Zhang
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

2.  Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes.

Authors:  Yuichi Horikoshi; Yasheng Yan; Maia Terashvili; Clive Wells; Hisako Horikoshi; Satoshi Fujita; Zeljko J Bosnjak; Xiaowen Bai
Journal:  Cells       Date:  2019-09-17       Impact factor: 6.600

3.  Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro.

Authors:  Woan Ting Tay; Yi-Hsien Fang; Suet Theng Beh; Yen-Wen Liu; Ling-Wei Hsu; Chia-Jui Yen; Ping-Yen Liu
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

Review 4.  Strategies and Challenges to Improve Cellular Programming-Based Approaches for Heart Regeneration Therapy.

Authors:  Lin Jiang; Jialiang Liang; Wei Huang; Zhichao Wu; Christian Paul; Yigang Wang
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.